Clinical trial for Genetic Predisposition
Official title Using the EHR to Advance Genomic Medicine Across a Diverse Health System
ClinicalTrials.gov ID: NCT06377033
What this study is testing
- What it's testing
- The study wants to see if using computer‑based prompts and easy ordering tools can increase the use of genetic testing and improve care for people with conditions that can be affected by genetics.
- Who it's for
- Adults who have or are at risk for conditions such as genetic heart disease, blood vessel problems, certain cancers, and neurological disorders.
- What's involved
- Participants will have their doctors use special software in the electronic health record to order or refer for genetic tests. Patients may receive reminders or information through the system and sign consent electronically.
- Time commitment
- The trial will run for several months, with patients and doctors interacting with the system during routine visits; no extra visits or tests are required beyond normal care.
- Time commitment: about 3 years
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older
- diagnosed with one of the study conditions
You likely can't join if
- Under 18 years of age
- not diagnosed with one of the study conditions
The study team makes the final eligibility decision.
Where it is enrolling
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 3 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.